Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study
Clinical Lung Cancer · 2026-11 · 27 (9) · 20-24
DOI: 10.1016/j.cllc.2026.08.013 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Lung Cancer, 2026-11. Verfasst von Mumtu Lalla und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Lank Cancer Center, Beth Israel Lahey Health - Needham, Needham, MA. Electronic address: mlalla@bidmc.harvard.edu. Hauptthemen laut MEDLINE: Lung Neoplasms, Black or African American, Neutrophils, Neutropenia. Die Arbeit nennt 13 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: African American patients remain underrepresented in cancer clinical trials, and minimum absolute neutrophil count (ANC) eligibility thresholds may disproportionately exclude individuals with Duffy-null associated neutrophil count (DANC), a common biologic variant associated with lower baseline ANC and no clearly increased infection risk. We evaluated whether African American patients with advanced lung cancer and lower baseline ANC experience greater chemotherapy-related complications. METHODS: We conducted a retrospective cohort study of African American patients with stage IV lung cancer receiving first-line chemotherapy at a single center. Patients were grouped by baseline ANC (≤ 2500 vs. > 2500 cells/µL) as a pragmatic proxy for potential DANC. We collected demographic, clinical, and ANC data at baseline, end of cycle 1, and nadir during the first 4 chemotherapy cycles, comparing infectious complications, febrile neutropenia, antibiotic and growth factor use, and dose modifications between the groups. RESULTS: Among 127 eligible patients, 9 (7.1%) had baseline ANC ≤ 2500 cells/μL. These patients had more severe post-treatment neutropenia (P = .004) and a lower median ANC nadir (P = .05) compared to those with baseline ANC > 2500 cells/µL. No significant differences were observed in infection rates, febrile neutropenia, antibiotic use, or growth factor use. CONCLUSION: Lower baseline ANC was associated with greater neutropenia severity but not increased infectious complications in African American patients with advanced lung cancer. These findings suggest uniform ANC-based eligibility thresholds merit reconsideration, supporting prospective studies incorporating Duffy status to promote equitable trial eligibility and toxicity management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Lank Cancer Center, Beth Israel Lahey Health - Needham, Needham, MA. Electronic address: mlalla@bidmc.harvard.edu.
- Department of Internal Medicine, Jacobi Medical Center, Bronx, NY.
- Department of Oncology, Moffitt Cancer Center, Tampa, FL.
- Department of Oncology, Medical College of Wisconsin, Milwaukee, WI.
- Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY.
- Department of Internal Medicine, Advent Health, Orlando, FL.
Zitieren
APA
Lalla, M., Du, S., Gor, R., Narvel, H., D'Aiello, A., Shivakumar, J., Yusuf, H., Maia, C. M., Beumer, J. H., & Cheng, H. (2026). Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study. Clinical Lung Cancer, 27(9), 20-24. https://doi.org/10.1016/j.cllc.2026.08.013
Vancouver
Lalla M, Du S, Gor R, Narvel H, D'Aiello A, Shivakumar J, et al. Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study. Clinical Lung Cancer. 2026;27(9):20-24. doi:10.1016/j.cllc.2026.08.013
BibTeX
@article{Lalla2026,
author = {Lalla, Mumtu and Du, Simo and Gor, Rajvi and Narvel, Hiba and D'Aiello, Angelica and Shivakumar, Jeevan and Yusuf, Hasiya and Maia, Catarina Martins and Beumer, Jan H and Cheng, Haiying},
title = {Low Baseline Absolute Neutrophil Count and Chemotherapy Safety in African American Patients with Advanced Lung Cancer: A Retrospective Cohort Study},
journal = {Clinical Lung Cancer},
year = {2026},
volume = {27},
number = {9},
pages = {20--24},
doi = {10.1016/j.cllc.2026.08.013}
}
EUVIMED